https://www.avient.com/investor-center/news/avient-hold-fourth-quarter-2024-conference-call
A recording of the webcast and the slide presentation will be available at avient.com/investors/events-presentations immediately following the conference call and will be accessible for one year.
https://www.avient.com/news/polyone-joins-leading-brands-eliminate-hazardous-chemicals-discharge-textile-manufacturing
Bringing associate members on board with a strong track record of delivering specialty solutions broadens our technical knowledge base,” explains Cheryl Kreindler, ZDHC Program Manager.
https://www.avient.com/news/polyone-announces-plans-new-innovation-center-asia
Patterson, executive vice president and chief operating officer said, “In 2013 we delivered record revenues and operating income in Asia.
https://www.avient.com/news/polyone-expands-capacity-metal-replacement-technologies
PolyOne has a proven track record of working closely with our customers to develop innovative specialty formulations that meet their specific performance needs,” said Craig Nikrant, president, Global Specialty Engineered Materials, PolyOne Corporation.
https://www.avient.com/news/polyone-announces-20-increase-quarterly-dividend
The $0.12 per share will be paid on January 7, 2016 to stockholders of record on December 18, 2015.
https://www.avient.com/sites/default/files/2024-03/2024 Proxy Statement %28Filed%29.pdf
Shareholders as of the close of business on March 19, 2024, the record date for the Annual Meeting (the
"Record Date"), may attend and participate in the Annual Meeting.
5) Performance shares granted in 2014 reflect a prorated amount in cases of disability or death.
VOTING AT THE MEETING
Shareholders of record at the close of business on the Record Date, March 19, 2024, are entitled to vote at
the Annual Meeting.
https://www.avient.com/investor-center/news/polyone-signs-definitive-agreement-acquire-clariant-color-and-additive-masterbatch-business
A recording of the webcast and the investor presentation will be available at polyone.com/investor.
In addition, a recording of the audio will be available for one week, beginning at
To listen to this recording, dial 1-855-859-2056 (domestic) or 1-404-537-3406 (international) and provide conference ID number 5289238.
https://www.avient.com/investor-center/news/polyone-raises-outlook-fourth-quarter-2019-adjusted-earnings
A recording of the webcast and the investor presentation will be available at polyone.com/investor.
In addition, a recording of the audio will be available for one week, beginning at
To listen to this recording, dial 1-855-859-2056 (domestic) or 1-404-537-3406 (international) and provide conference ID number 5289238.
https://www.avient.com/investor-center/news/polyone-announces-first-quarter-2018-results
Adjusted EPS expands 15% to a new first quarter record of $0.68 driven by a 20% increase in operating income from Color, Additives and Inks
A recording of the call will also be available for one week, beginning at
To listen to this recording, dial 1-855-859-2056 (domestic) or 1-404-537-3406 (international) and enter conference ID number 6747028.
https://www.avient.com/sites/default/files/resources/Application%2520Bulletin%2520Resilience%2520HC.pdf
Public Health Service, the incidence of hospital-acquired infections
(HAI’s), such as MRSA and VRE, has increased approximately 36% in the last 20 years and
today causes nearly 100,000 deaths annually.